0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

New biomarkers for diagnosis of bladder cancer: a bibliometric analysis

Authors

Background/Objectives: Bladder cancer is a multifactorial disease, ranking as the 10th most common cancer globally and the fourth most common cancer in men and the ninth in women in the Western world. This bibliometric analysis aims to identify and evaluate scientific literature addressing new biomarkers for bladder cancer diagnosis, as well as to identify the most prolific organizations, authors, journals, countries, and keywords within this research domain.
Methods: An electronic search was conducted using Elsevier's Scopus database. From a total of 940 retrieved papers (published between 2019 and 2024), 493 were selected. For data analysis and visualization, the titles of articles, year of publication, countries, authors, journals, articles, and keywords were analyzed using Microsoft Excel, VOSviewer, and Biblioshiny.
Results: China published the most papers (200 articles) and received the highest number of citations, followed by the USA. While some countries, such as Egypt and India, published exclusively Single Country Publications (SCPs), others demonstrated a higher level of international collaboration, with at least half of their publications being Multi-Country Publications (MCPs). Countries with higher rates of MCPs were Greece (66.6%), Italy (53.8%), Korea, and France (50%). The journals that produced the most publications and received the highest number of citations were Cancers, International Journal of Molecular Sciences, and Frontiers in Oncology, confirming their role in producing high-impact research.
Conclusions: The consistent distribution of publications over the years considered indicates a sustained interest in this field.

Karam JA, Lotan Y, Shariat SF. Urine cytology and commercially available urine-based markers for monitoring of bladder urothelial carcinoma. Lab Med. 2007; 38:48-52. DOI: https://doi.org/10.1309/DTJXKUDMQ49P80LR
Feil G, Stenzl A. Tumor marker tests in bladder cancer. Actas Urol Esp. 2006; 30:38-45. DOI: https://doi.org/10.1016/S0210-4806(06)73394-0
Mitropoulos D, Adamakis I, Perimenis P. Contemporary diagnosis of bladder cancer. Expert Opin Med Diagn. 2008; 2:713-20. DOI: https://doi.org/10.1517/17530059.2.6.713
Lopez-Beltran A, Cheng L, Gevaert T, et al. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020; 20:231-43. DOI: https://doi.org/10.1080/14737159.2020.1699791
Linscott JA, Miyagi H, Murthy PB, et al. From Detection to cure - emerging roles for urinary tumor DNA (utDNA) in bladder cancer. Curr Oncol Rep. 2024; 26:945-58. DOI: https://doi.org/10.1007/s11912-024-01555-0
Lee HH, Kim SH. Review of non-invasive urinary biomarkers in bladder cancer. Transl Cancer Res. 2020; 9:6554-64. DOI: https://doi.org/10.21037/tcr-20-1990
Jordaens S, Oeyen E, Willems H, et al. Protein biomarker discovery studies on urinary sEV fractions separated with UF-SEC for the first diagnosis and detection of recurrence in bladder cancer patients. Biomolecules. 2023; 13:932. DOI: https://doi.org/10.3390/biom13060932
Satam H, Joshi K, Mangrolia U, et al. Next-generation sequencing technology: current trends and advancements. Biology. 2023;12:997. DOI: https://doi.org/10.3390/biology12070997
Gogalic S, Sauer U, Doppler S, et al. Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer. Biomarkers. 2017; 1-8. DOI: https://doi.org/10.1080/1354750X.2016.1276628
Tan WS, Tan WP, Tan MY, et al. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treat Rev. 2018; 69:39-52. DOI: https://doi.org/10.1016/j.ctrv.2018.05.012
Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: How great is the impact? Scientometrics 2015;105:1809-31. DOI: https://doi.org/10.1007/s11192-015-1645-z
Hossain MM. Current status of global research on novel coronavirus disease (COVID-19): a bibliometric analysis and knowledge mapping. F1000Research. 2020; 9:374. DOI: https://doi.org/10.12688/f1000research.23690.1
Chahrour M, Assi S, Bejjani M, et al. A bibliometric analysis of COVID-19 research activity: a call for increased output. Cureus 2020;12:e7357. DOI: https://doi.org/10.7759/cureus.7357
Kelly JC, Glynn RW, O’Briain DE, et al. The 100 classic papers of orthopaedic surgery: a bibliometric analysis. J Bone Joint Surg Br. 2010; 92-B:1338-43. DOI: https://doi.org/10.1302/0301-620X.92B10.24867
Vaishya R, Gopinathan P, Gupta BM, et al. Scholarly trends in global orthopedics research published through the Journal of Orthopaedics: A bibliometric analysis from 2013 to 2024. J Orthop. 2025; 60:35-43. DOI: https://doi.org/10.1016/j.jor.2024.08.013
Zhang Y, Xiao F, Lu S, et al. Research trends and perspectives of male infertility: a bibliometric analysis of 20 years of scientific literature. Andrology. 2016; 4:990-1001. DOI: https://doi.org/10.1111/andr.12204
Akbari R, Hantoushzadeh S, Panahi Z, et al. A bibliometric review of 35 years of studies about preeclampsia. Front Physiol. 2023; 14:1110399. DOI: https://doi.org/10.3389/fphys.2023.1110399
Alam BF, Nayab T, Ali S, et al. Current scientific research trends on salivary biomarkers: a bibliometric analysis. Diagnostics. 2022;12:1171. DOI: https://doi.org/10.3390/diagnostics12051171
Wu CC, Islam MdM, Poly TN, Weng YC. Artificial intelligence in kidney disease: a comprehensive study and directions for future research. Diagnostics. 2024; 14:397. DOI: https://doi.org/10.3390/diagnostics14040397
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010; 8:336-41. DOI: https://doi.org/10.1016/j.ijsu.2010.02.007
Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017; 11:959-75. DOI: https://doi.org/10.1016/j.joi.2017.08.007
Han J, Kang HJ, Kim M, Kwon GH. Mapping the intellectual structure of research on surgery with mixed reality: bibliometric network analysis (2000-2019). J Biomed Inform. 2020; 109:103516. DOI: https://doi.org/10.1016/j.jbi.2020.103516
Alix-Panabières C, Pantel K. Liquid biopsy: from discovery to clinical application. Cancer Discov. 2021; 11:858-73. DOI: https://doi.org/10.1158/2159-8290.CD-20-1311
Usuba W, Urabe F, Yamamoto Y, et al. Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Sci. 2019; 110:408-19. DOI: https://doi.org/10.1111/cas.13856
Chen X, Zhang J, Ruan W, et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J Clin Invest. 2020; 130:6278-89. DOI: https://doi.org/10.1172/JCI139597
Zhang S, Du L, Wang L, et al. Evaluation of serum exosomal Lnc RNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer. J Cell Mol Med. 2019; 23:1396-405. DOI: https://doi.org/10.1111/jcmm.14042
Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer—A population-based cohort study. Int J Cancer. 2020;146:692-8. DOI: https://doi.org/10.1002/ijc.32303
Huang J, Jiang Y, Li J, et al. A renal-clearable macromolecular reporter for near-infrared fluorescence imaging of bladder cancer. Angew Chem Int Ed. 2020; 59:4415-20. DOI: https://doi.org/10.1002/anie.201911859
Mi X, Zou B, Zou F, Hu J. Permutation-based identification of important biomarkers for complex diseases via machine learning models. Nat Commun. 2021; 12:3008. DOI: https://doi.org/10.1038/s41467-021-22756-2
Wang Y, Li Z, Lin Q, et al. Highly sensitive detection of bladder cancer-related miRNA in urine using time-gated luminescent biochip. ACS Sens. 2019; 4:2124-30. DOI: https://doi.org/10.1021/acssensors.9b00927
Yu C, Longfei L, Long W, et al. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells. J Cell Physiol. 2019; 234:1346-53. DOI: https://doi.org/10.1002/jcp.26929
Laukhtina E, Shim SR, Mori K, et al. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol. 2021; 4:927-42. DOI: https://doi.org/10.1016/j.euo.2021.10.003

How to Cite

Falabella, R., De Simone, V., Crocetto, F., Del Giudice, F., Porreca, A., Foschi, N., Barone, B., Di Gianfrancesco, L., Di Pasquale, V., & Caputo, V. F. (2025). New biomarkers for diagnosis of bladder cancer: a bibliometric analysis. Archivio Italiano Di Urologia E Andrologia, 97(1). https://doi.org/10.4081/aiua.2025.13396

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.